منابع مشابه
Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
BACKGROUND The aim of the study was to determine the most common pharmacological strategies used in the management of major depressive disorder (MDD) after an inadequate response to first-line antidepressant treatment in clinical practice. METHODS Multicenter, non-interventional study in adult outpatients with a DSM-IV-TR diagnosis of MDD and inadequate response to first-line antidepressant m...
متن کاملWhich First -- Attitude or Behavior?
It's fitting that my first contribution in the new " Attitude and Behavior " column addresses the age-old question, which comes first-attitude or behavior? Actually, the more practical question is which should be targeted for change first-attitude or behavior? Education typically addresses " attitude " or internal and subjective dimensions of people by attempting to " think people into acting d...
متن کاملPrimary stroke prevention and hypertension treatment: which is the first-line strategy?
Hypertension (HT) is considered the main classic vascular risk factor for stroke and the importance of lowering blood pressure (BP) is well established. However, not all the benefit of antihypertensive treatment is due to BP reduction per se, as the effect of reducing the risk of stroke differs among classes of antihypertensive agents. Extensive evidences support that angiotensin-converting enz...
متن کاملFirst-line and second-line antiretroviral therapy.
January, 2004, administration of measles vaccine was recommended between 12 and 24 months of age, instead of between 12 and 15 months when children have the greatest risk of contracting measles. There is no established system to check vaccination status on entry to the school systems. Strong political and social desire has to be inspired, and vigorous educational campaigns for policy makers and...
متن کاملManaging first-line failure
WHO standard of care for failure of a first regimen, usually 2N(t)RTI's and an NNRTI, consists of a ritonavir-boosted protease inhibitor with a change in N(t)RTI's. Until recently, there was no evidence to support these recommendations which were based on expert opinion. Two large randomized clinical trials, SECOND LINE and EARNEST both showed excellent response rates (>80%) for the WHO standar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of General Practice
سال: 2019
ISSN: 0960-1643,1478-5242
DOI: 10.3399/bjgp19x701405